Methyl aminolevulinate photodynamic therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Methyl aminolevulinate photodynamic therapy, covering 2014-07-23 to 2017-10-27. Get the full timeline:
Most recent: Clinical Trial Update: New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) [NA]